Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for Abdominal Aortic Aneurysms
NCT02345590Phase 4Unknown
- Start
- May 2015
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in abdominal aortic aneurysm (AAA) comparing Eplerenone with Placebo (2 arms). Primary endpoint: abdominal aortic aneurysm maximum orthogonal diameter at 12 months. Status: unknown.
02
Drugs
eplerenone
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT02345590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02345590.